Psoriatic arthritis
4 years ago
PsA pts have ^ risk of developing polyclonal gammopathy, MGUS, and possibly progression to lymphoproliferative malignancy. #ABS0338 #ACR20 @RheumNow https://t.co/jl6sq1KcKZ https://t.co/BHrGKPXs3a
4 years ago
Do you screen your PsA patients for lymphoproliferative disease? @RheumNow #ACR20 #ABS0338
4 years ago
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by BMS, @HorizonNews , @SanofiGenzyme, @Novartis. All content chosen by RheumNow & its Faculty.
4 years ago
Dr. C. Bakewell reminds us that entheses can show inflammation and chronic changes. Pearl: Be sure to look at MSUS of the digits for enthesitis. #ACR20 #ACRbest @RheumNow https://t.co/D3nLGGv4ko
Spondyloarthritis at ACR 2020: Dr. Lianne Gensler
San Francisco-based rheumatologist Dr. Lianne Gensler examines a wide range of spondyloarthritis topics at ACR 2020, including how to join up with others interested in spondyloarthritis; enthesitis; the utility of MRI for the diagnosis for axSpA; novel treatments; and the impact of drugs on disease modification.
Early diagnosis of arthritis improves outcomes and quality of life in patients with psoriasis. A longitudinal cohort study shows that the development of PsA within clinically meaningful time frames…
Each pharmaceutical company has spent months and years preparing to present and highlight their featured clinical trials and abstracts at ACR 2020. This is our selection of their best studies…
4 years ago
Efficacy & Safety Deucravacitinib (BMS-986165), Oral, Selective TyK2 Inhib in Patients with Active PsA Results from a Phase 2, RDBPC Trial https://t.co/s3V5NtRpuW results-from-a-phase-2-randomized-double-blind-plac/ #psa #tyk2inhib Efficacy in PsA ?top of dose response
Inadequate Response in Spondylitis: Dr. Olga Petryna
Dr. Petryna discusses two abstracts being presented at the ACR 2020 meeting: #0359 and #0371.
Axial Involvement in Psoriatic Arthritis: Dr. Eric Ruderman Perspective
Dr. Eric Ruderman, Chicago, IL., provides his perspective on ACR 2020 coverage of axial involvement in Psoriatic Arthritis. During his remarks, he discusses ACR abstracts #0344, #1372, #2025 and #0505.
Poster Hall